Please use this identifier to cite or link to this item: https://doi.org/10.2174/1566523044578095
Title: Exploiting internal ribosome entry sites in gene therapy vector design
Authors: Ngoi, S.M.
Chien, A.C.
Lee, C.G.L. 
Keywords: Cellular IRES
Co-expression
Gene therapy
Internal ribosome entry site
Viral IRES
Issue Date: Mar-2004
Source: Ngoi, S.M., Chien, A.C., Lee, C.G.L. (2004-03). Exploiting internal ribosome entry sites in gene therapy vector design. Current Gene Therapy 4 (1) : 15-31. ScholarBank@NUS Repository. https://doi.org/10.2174/1566523044578095
Abstract: Efficient and regulated co-expression of multiple genes is an important consideration in the design of gene therapy vectors. While the augmentation of a single therapeutic gene is often sufficient for gene therapy of simple mendelian disorders, strategies for the treatment of complex disorders and infectious diseases necessitate the introduction of multiple genes into the cell. Complex disorders such as cancer often involve mutations in multiple genes and a combination strategy targeting different defective genes simultaneously are often more effective than any single strategy. Likewise, approaches for treating infectious diseases such as HIV-1 (human immunodeficiency virus) often involve the blocking of multiple steps of the viral replication pathway simultaneously to prevent the emergence of resistant strains of the virus. Even for the treatment of single gene defects, the additional incorporation of a selectable marker gene is often necessary to achieve sustained expression of the therapeutic gene in the cells. Among the several different strategies to co-express multiple genes, the incorporation of an IRES (internal ribosome entry site) into gene therapy vector design represents one of the more promising strategies. IRES functions as a ribosome-landing pad for the efficient internal initiation of translation ensuring coordinate expression of several genes and are located at the 5′UTR (5′ untranslated regions) of these genes. Currently, the most popular IRES utilized for gene therapy is the IRES from the EMCV (encephalomyocarditis virus). However, the major caveat with present vector systems utilizing this IRES is that the expression of the downstream gene is significantly less efficient than the upstream gene. This review will examine the growing list of naturally occurring and synthetic IRESes and how they can be exploited for human gene therapy. © 2004 Bentham Science Publishers Ltd.
Source Title: Current Gene Therapy
URI: http://scholarbank.nus.edu.sg/handle/10635/107799
ISSN: 15665232
DOI: 10.2174/1566523044578095
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

67
checked on Feb 21, 2018

WEB OF SCIENCETM
Citations

65
checked on Jan 16, 2018

Page view(s)

32
checked on Feb 18, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.